Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model

Physics in Medicine and Biology

Volumn 55, Issue 5, 2010, Pages 1381-1393

  Larocque, Matthew P ^a,b   Syme, Alasdair ^a,b   Yahya, Atiyah ^a,b   Wachowicz, Keith ^a   Allalunis Turner, Joan ^a,b   Fallone, B Gino ^a,b  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AFTER-TREATMENT; APPARENT DIFFUSION COEFFICIENT; BASELINE VALUES; EXTERNAL BEAM RADIATION THERAPY; FRACTIONATED RADIOTHERAPY; MAXIMUM VALUES; MOUSE MODELS; MULTIPLE POINTS; PRE-TREATMENT; TEMPORAL EVOLUTION; TOTAL DOSE; TRANSVERSE RELAXATION TIME; TREATMENT GROUP; TUMOR RESPONSE; TUMOR XENOGRAFTS; UNTREATED CONTROL;

MAGNETIC RESONANCE IMAGING; RADIOTHERAPY; RESONANCE; SURFACE DIFFUSION; TUMORS;

MULTICARRIER MODULATION;

ANIMAL; ARTICLE; CELL TRANSFORMATION; DIFFUSION; DISEASE MODEL; HUMAN; METABOLISM; METHODOLOGY; MOUSE; NEOPLASM; PATHOLOGY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; TIME; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DIFFUSION; DISEASE MODELS, ANIMAL; DOSE FRACTIONATION; HUMANS; MICE; NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; TIME FACTORS;

EID: 76849111726     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/55/5/008     Document Type: Article

References (36)

1. Andrews D W, Bednarz G, Evans J J and Downes B 2006 A review of 3 current radiosurgery systems Surg. Neurol. 66 559-64
2. Chenevert T L, McKeever P E and Ross B D 1997 Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging Clin. Cancer Res. 3 1457-66
3. Chenevert T L, Stegman L D, Taylor J M G, Robertson P L, Greenberg H S, Rehemtulla A and Ross B D 2000 Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors J. Natl. Cancer Inst. 92 2029-36
4. Eccles C L, Haider E A, Haider M A, Fung S, Lockwood G and Dawson L A 2009 Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations Acta Oncol. 48 1034-43
5. Evelhoch J, Garwood M, Vigneron D, Knopp M, Sullivan D, Menkens A, Clarke L and Liu G 2005 Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report Cancer Res. 65 7041-4
6. Franko A, Parliament M, Allalunis-Turner J and Wolokoff B 1998 Variable presence of hypoxia in M006 human glioma spheroids and in spheroids and xenografts of clonally derived sublines Br. J. Cancer 78 1261-8
7. Gillies R and Morse D 2005 In vivo magnetic resonance spectroscopy in cancer Annu. Rev. Biomed. Eng. 7 287-326
8. Goldman M, Boxerman J L, Rogg J M and Noren G 2006 Utility of apparent diffusion coefficient in predicting the outcome of gamma knife-treated brain metastases prior to changes in tumor volume: a preliminary study J. Neurosurg. 105 S175-82
9. Hamstra D A et al 2008 Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival J. Clin. Oncol. 26 3387-94
10. Hamstra D A, Rehemtulla A and Ross B D 2007 Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology J. Clin. Oncol. 25 4104-9 (Pubitemid 47495868)
11. Harry V N, Semple S I, Gilbert F J and Parkin D E 2008 Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer Gynecol. Oncol. 111 213-20
12. Henning E C, Azuma C, Sotak C H and Helmer K G 2007a Multispectral quantification of tissue types in a RIF-1 tumor model with histological validation. Part I Magn. Reson. Med. 57 501-12
13. Henning E C, Azuma C, Sotak C H and Helmer K G 2007b Multispectral tissue characterization in a RIF-1 tumor model: monitoring the ADC and T2 responses to single-dose radiotherapy. Part II Magn. Reson. Med. 57 513-9
14. Jaffe C C 2006 Measures of response: RECIST, WHO, and new alternatives J. Clin. Oncol. 24 3245-51
15. Jennings D, Hatton B N, Guo J, Galons J-P, Trouard T P, Raghunand N, Marshall J and Gillies R J 2002 Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI Neoplasia 4 255-62
16. Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A and Poptani H 2009 Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck Clin. Cancer Res. 15 986-94
17. Larocque M P, Syme A, Yahya A, Wachowicz K, Allalunis-Turner J and Fallone B G 2009 Temporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy Med. Phys. 36 2948-54
18. Le Bihan D, Breton E, Lallemand D, Aubin M-L, Vignaud J and Laval-Jeantet M 1988 Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging Radiology 168 497-505 (Pubitemid 18184480)
19. Lee K C et al 2007 Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy Clin. Cancer Res. 13 443-50
20. Mardor Y et al 2003 Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging J. Clin. Oncol. 6 1094-100
21. McConville P, Hambardzymyan D, Moody J B, Leopold W R, Kreger A R, Woolliscroft M J, Rehemtulla A, Ross B D and Holland E C 2007 Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma Clin. Cancer. Res. 13 2897-904
22. Mitchell D G, Burk D L Jr, Vinitski S and Rifkin M D 1987 The biophysical basis of tissue contrast in extracranial MR imaging Am. J. Roentgenol. 149 831-7
23. Moffat B A et al 2005 Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response Proc. Natl. Acad. Sci. USA 102 5524-9
24. Nishimura D G 1996 Principles of Magnetic Resonance Imaging (Palo Alto, CA: Stanford University Press)
25. Ross B D et al 2003 Evaluation of cancer therapy using diffusion magnetic resonance imaging Mol. Cancer Ther. 2 581-6
26. Roth Y, Tichler T, Kostenich G, Ruiz-Cabello J, Maier S E, Cohen J S, Orenstein A and Mardor Y 2004 High-b-value diffusion-weighted MR imaging for pretreatment predication and early monitoring of tumor response to therapy in mice Radiology 232 685-92
27. Schepkin V D, Chenevert T L, Kuszpit K, Lee K C, Meyer C R, Johnson T D, Rehemtulla A and Ross B D 2006 Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors Magn. Reson. Imaging 24 273-8
28. Sorensen A G 2006 Magnetic resonance as a cancer imaging biomarker J. Clin. Oncol. 24 3274-81
29. Stegman L D, Rehemtulla A, Hamstra D A, Rice D J, Jonas S J, Stout K L, Chenevert T L and Ross B D 2000 Diffusion MRI detects early events in the response of glioma model to the yeast cytosine deaminase gene therapy strategy Gene Ther. 7 1005-10
30. Sun Y, Mulkern R V, Schmidt K, Doshi S, Albert M S, Schmidt N O, Ziu M, Black P, Carrol R and Kiernan M W 2004 Quantification of water diffusion and relaxation times of human U87 tumors in a mouse model NMR Biomed. 17 399-404
31. Szafer A, Zhong J, Anderson A W and Gore J C 1995 Diffusion-weighted imaging in tissues: theoretical models NMR Biomed. 8 289-96
32. Therasse P et al 2000 New guidelines to evaluate the response to treatment in solid tumors J. Natl. Cancer Inst. 92 205-16 (Pubitemid 30099779)
33. Yankeelov T E et al 2007 Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results Magn. Reson. Imaging 25 1-13
34. Yezhelyev M V, Gao X, Xing Y, Al-Hajj A, Nie S and O'Regan R M 2006 Emerging use of nanoparticles in diagnosis and treatment of breast cancer Lancet Oncol. 7 657-67
35. Zhao M, Beauregard D A, Loizou L, Davletov B and Brindle K M 2001 Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent Nat. Med. 7 1241-4
36. 1H-NMR spectroscopy in a murine tumor in vivo Br. J. Cancer 73 61-5